Aspirin® protect 300 mg Magensaftresistente Tablette Acetylsalicylsäure
Sponsors
University College London, Assistance Publique Hopitaux De Paris
Conditions
Breast cancerColorectal adenomasLynch syndromecolon canceroesophageal cancerprostate cancerrectal cancerstomach cancer
Phase 3
Add-Aspirin: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non metastatic solid tumours.
Not yet recruitingCTIS2024-511306-23-00
Target: 204Updated: 2025-06-24
AAS-Lynch - Assessment of the effect of a daily chemoprevention by aspirin low-dose of new or recurrent colorectal adenomas in patients with Lynch syndrome
Active, not recruitingCTIS2024-516601-23-00
Start: 2017-11-14Target: 852Updated: 2025-03-13